FASEB Conference: Genome Engineering: Research and...
CMN Briefs
May. 7, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Avance Biosciences
Company type: CRO
Main focus: Genomics and molecular biology assays
Company stage: Actively providing services
Diseases: None
Genome-editing tool: N/A
Funding stage: N/A
Location: Houston, Texas, USA
Website: https://www.avancebio.com
Pipeline: N/A
Partners:
Avance Biosciences primarily focuses on providing CGMP- and GLP-compliant genomics and molecular biology services. The company offers sensitive and high-throughput amplicon sequencing to accurately quantify on-target editing efficiency and off-target editing events at predicted loci, including chromosome translocation events. They also offer a range of services related to genotyping, gene expression analysis, and other molecular biology techniques for various applications including CRISPR and CAR-T cells.
